Apigenin for Sleep: What the Research Actually Shows (2026)

What Is Apigenin?

Apigenin (4',5,7-trihydroxyflavone) is a natural flavonoid found in chamomile flowers, parsley, celery, and other plants. It is the primary bioactive compound in chamomile responsible for the herb's traditional sedative and anxiolytic reputation. Chemically, it is a flavone, a subclass of flavonoids with a characteristic three-ring structure.

Chamomile (Matricaria chamomilla) is one of the most widely consumed herbal teas in the world and has long been used as a calming drink. Researchers singled out apigenin when they found it binds benzodiazepine receptors in the brain (Viola et al., 1995).

Beyond chamomile, apigenin is found in parsley, celery, thyme and oregano. Everyday dietary intake is small compared with the 50 mg doses sold as supplements.

Apigenin gained mainstream attention after neuroscientist Andrew Huberman recommended 50 mg of isolated apigenin nightly on his podcast as a sleep-supporting supplement. This recommendation rapidly drove consumer demand, making apigenin one of the fastest-growing supplement ingredients of 2024–2026 — despite the absence of clinical trials specifically testing this dose for sleep.

How Apigenin Affects the Brain

Three mechanisms are proposed. In mice, apigenin binds the benzodiazepine site on GABA-A receptors and has anxiolytic and mild sedative effects without anticonvulsant or muscle-relaxant activity (Viola et al., 1995). It inhibits CD38, an enzyme that degrades NAD+, and raised NAD+ in obese mice (Escande et al., 2013). It also acts on inflammatory pathways (Kramer et al., 2024). All three come from laboratory and animal work.

GABA-A receptor modulation. Apigenin binds the benzodiazepine site of GABA-A receptors, the site targeted by diazepam. In mice, it reduced anxiety-related behavior and had a slight sedative effect, but unlike benzodiazepines it was not anticonvulsant or muscle relaxant (Viola et al., 1995). Whether supplement doses reach active levels in the human brain is unknown.

CD38 inhibition. CD38 is the main enzyme that breaks down NAD+ in mammals. Apigenin inhibits CD38, raised NAD+ in cell cultures and in obese mice, and reduced protein acetylation, consistent with higher sirtuin activity (Escande et al., 2013). A 2024 review proposes this as a link between apigenin, aging and sleep (Kramer et al., 2024).

Anti-inflammatory effects. Apigenin acts on several inflammatory pathways in laboratory studies (Kramer et al., 2024). Chronic inflammation is linked to poor sleep, so this could in theory contribute, but it has not been tested in sleep trials.

Clinical Evidence: What Has Actually Been Tested in Humans

Chamomile extract, not isolated apigenin, provides the human evidence. In older adults, 200 mg of chamomile extract twice daily for 28 days improved sleep quality scores versus placebo (Adib-Hajbaghery & Mousavi, 2017). A 2024 meta-analysis of 10 studies (772 participants) found a significant improvement in PSQI scores and fewer night awakenings in most studies that measured them, but no improvement in sleep duration, sleep efficiency or daytime functioning (Kazemi et al., 2024). No trial has tested 50 mg of isolated apigenin on its own for sleep.

Chamomile for sleep in older adults. Elderly nursing home residents took 200 mg chamomile extract capsules or placebo capsules twice daily for 28 days. Sleep quality on the Pittsburgh Sleep Quality Index was significantly better in the chamomile group afterward (Adib-Hajbaghery & Mousavi, 2017).

Chamomile for insomnia (Zick et al., 2011). A RCT of 34 adults with chronic primary insomnia received 540 mg of chamomile extract or placebo daily for 28 days. Sleep diary measures showed trends toward improvement in daytime functioning but did not reach statistical significance for primary sleep measures. The authors noted the small sample size as a limitation (Zick et al., 2011).

Chamomile meta-analysis. This 2024 review included 10 studies with 772 participants. Pooled PSQI scores improved (weighted mean difference −1.88), sleep onset improved in three of four studies and night awakenings in two of three, while sleep duration, sleep efficiency and daytime functioning did not improve (Kazemi et al., 2024).

The critical gap. These trials used whole chamomile extract, which contains apigenin alongside other active compounds such as bisabolol and chamazulene. The apigenin delivered by the extract trials was far below the 50 mg in supplements, and no trial has tested isolated apigenin by itself for sleep.

The 50 mg Dose: Where Does It Come From?

The 50 mg dose became popular through Andrew Huberman's podcast, not through a clinical trial. The first randomized trial to include it, published in 2026, gave 103 healthy active adults a morning adaptogen blend, an evening blend (2 g magnesium L-threonate, 200 mg L-theanine and 50 mg apigenin), both, or placebo for two weeks. The stress and sleep benefits came from the morning adaptogens, not from the apigenin-containing evening blend (Mastrofini et al., 2026).

When scientists study a compound's receptor binding, they establish concentrations that produce effects in cell cultures and animal models. Apigenin's GABA-A binding affinity and anxiolytic effects in rodents are well-documented. Translating these preclinical doses to human oral supplementation involves significant pharmacokinetic uncertainty, oral bioavailability, first-pass metabolism, blood-brain barrier penetration, and brain tissue distribution all affect whether a given oral dose achieves receptor-relevant concentrations at the GABA-A receptor.

The 50 mg dose seems to come from practical reasoning: it is far above the apigenin content of the chamomile extracts used in trials and is a convenient capsule size. The 2026 trial is the first controlled test of it, and only in combination with other ingredients (Mastrofini et al., 2026).

Apigenin Dosage and How to Take It

If you choose isolated apigenin, 50 mg taken 30 to 60 minutes before bed is the common protocol, but it has no trial support on its own and showed no benefit as part of a blend (Mastrofini et al., 2026). Chamomile extract at 200 mg twice daily has positive trial data in older adults (Adib-Hajbaghery & Mousavi, 2017), and chamomile tea is the gentlest option.

Isolated apigenin (50 mg): the popular supplement dose, taken 30 to 60 minutes before bed. No trial supports it on its own for sleep.

Standardized chamomile extract (200 mg twice daily): the dose with positive RCT data for sleep quality in older adults (Adib-Hajbaghery & Mousavi, 2017).

Chamomile tea (1 to 2 cups): the traditional preparation. Like other herbal teas, chamomile reduces iron absorption if drunk with a meal (Hurrell et al., 1999), so have it away from iron-rich meals or iron supplements.

Safety and Side Effects

Human safety data for isolated apigenin are limited. Chamomile trials report few, mild adverse events (Hieu et al., 2019) (Kazemi et al., 2024). One real caution: a 2021 systematic review listed chamomile tea among herbs that may raise bleeding risk in people taking warfarin (Tan & Lee, 2021).

In a 26-week chamomile study, adverse event rates were low and similar to placebo (Mao et al., 2016). Unlike benzodiazepines, apigenin has not been linked to dependence, though long-term studies of the isolated compound are lacking.

Interactions to keep in mind: chamomile may raise bleeding risk with warfarin (Tan & Lee, 2021), and combining apigenin with other sedating agents or alcohol could add to drowsiness. People taking prescription sedatives or anticoagulants should check with their prescriber.

Apigenin and NAD+: The CD38 Connection

Beyond its GABA-A effects, apigenin inhibits CD38, the main NAD+-degrading enzyme in mammals, and raised NAD+ in obese mice (Escande et al., 2013). A 2024 review suggests this may connect apigenin to both aging and sleep, but the link to human sleep is untested (Kramer et al., 2024).

CD38 is an enzyme on immune and other cells that breaks down NAD+. Mice lacking CD38 have higher NAD+ and are protected against obesity and metabolic syndrome (Escande et al., 2013). NAD+ declines with age, and in mice apigenin can raise it by inhibiting CD38 (Kramer et al., 2024).

The original study characterized both quercetin and apigenin as CD38 inhibitors. In cells, apigenin lowered global protein acetylation, including acetylation of p53 and RelA-p65, and in obese mice it raised NAD+ (Escande et al., 2013).

The proposed link to sleep runs through the body clock. NAD+-dependent sirtuins help regulate circadian clock genes, so preserving NAD+ could in theory support steadier sleep-wake rhythms. This idea comes from reviews of animal research and has not been tested in a human sleep trial (Kramer et al., 2024).

This mechanism is distinct from apigenin's direct GABA-A receptor effects. The GABAergic action promotes acute relaxation and reduces sleep-onset anxiety, while the CD38/NAD+ mechanism addresses a deeper, metabolic cause of age-related sleep disruption. The combination of both mechanisms in a single compound is unusual and may explain why some users report improvements in sleep quality that go beyond simple sedation, including more restorative sleep, better morning alertness, and improved sleep consistency over time.

This NAD+ connection also links apigenin to the broader longevity supplement ecosystem. NMN and NR (nicotinamide riboside) boost NAD+ by providing precursors for its synthesis. Apigenin preserves NAD+ by inhibiting its degradation. The two approaches are complementary: one fills the tank, the other stops the leak. Some researchers and biohackers combine apigenin with NMN for this reason, though no clinical trial has evaluated this specific combination.

Apigenin vs. Other Natural Sleep Supplements

Compared to melatonin, magnesium glycinate, L-theanine, and valerian, apigenin has the weakest direct clinical evidence for sleep but the most interesting mechanistic profile. Magnesium glycinate and L-theanine have better-supported clinical data for sleep quality improvement. Melatonin addresses circadian timing rather than sleep quality. Apigenin's unique value is its dual GABAergic + NAD+-preserving mechanism, which no other natural sleep supplement shares.

Apigenin vs. Melatonin. Melatonin is a hormone that signals darkness to the brain, primarily affecting sleep timing (circadian phase) rather than sleep depth or quality. It has strong evidence for jet lag and shift-work sleep disorder, and moderate evidence for reducing sleep-onset latency. Apigenin operates through a completely different mechanism (GABA-A modulation + CD38 inhibition) and theoretically affects sleep quality rather than timing. They are complementary rather than competitive, melatonin for when you sleep, apigenin for how you sleep.

Apigenin vs. magnesium. Magnesium has better human sleep data than isolated apigenin: a meta-analysis of three trials in older adults with insomnia found that oral magnesium shortened the time to fall asleep by about 17 minutes compared with placebo (Mah & Pitre, 2021). For one evidence-based sleep supplement, magnesium has the firmer footing.

Apigenin vs. L-theanine. L-theanine from green tea promotes relaxation without sedation and, like apigenin, is not habit-forming. In the 2026 trial, an evening blend of L-theanine, magnesium L-threonate and apigenin did not improve sleep over two weeks in healthy adults (Mastrofini et al., 2026), so neither ingredient should be oversold.

Apigenin vs. valerian root. Valerian is one of the most tested herbal sleep aids, but its results have been inconsistent and its mechanism is debated. Apigenin has a cleaner mechanistic story but far fewer human data.

The combination approach. Stacking magnesium, L-theanine and apigenin has now been tested. In the 2026 trial of 103 healthy active adults, two weeks of the evening blend did not improve stress or sleep, while a morning blend of ashwagandha and Rhodiola rosea did (Mastrofini et al., 2026). Combinations may still help people with real sleep problems, but healthy adults should not expect much.

Who Should Consider Apigenin for Sleep?

Apigenin is best suited for people whose sleep difficulties are driven by pre-sleep anxiety or racing thoughts rather than pain, sleep apnea, or circadian disruption. Its anxiolytic mechanism is most relevant for people who lie awake with an active mind. It is not appropriate as a primary treatment for diagnosed insomnia, sleep apnea, or other clinical sleep disorders, which require medical evaluation and treatment.

Based on the available evidence and mechanism, apigenin supplementation makes the most sense for:

Pre-sleep anxiety sufferers. If your primary sleep barrier is an anxious, racing mind at bedtime, apigenin's GABA-A receptor modulation directly addresses this mechanism. The anxiolytic effect may reduce sleep-onset latency and improve the subjective experience of falling asleep.

Adults over 40 interested in NAD+ preservation. The CD38 inhibition mechanism is most relevant in the context of age-related NAD+ decline. Younger adults typically have adequate NAD+ levels and may not benefit as much from this secondary mechanism. For older adults already taking NMN or NR for NAD+ support, apigenin adds a complementary preservation mechanism.

People seeking non-sedating sleep support. Unlike melatonin (which can cause grogginess) or antihistamines (which suppress REM sleep), apigenin promotes relaxation without sedation, dependence, or next-day cognitive impairment. For people who want better sleep quality without feeling drugged, apigenin's gentle mechanism is appealing.

Supplement minimalists. If you prefer a single evening supplement rather than a complex stack, chamomile tea provides apigenin alongside other calming compounds in a time-tested delivery format. Two cups of strong chamomile tea 30–60 minutes before bed is the simplest and most natural approach to apigenin-supported sleep.

Who should not rely on apigenin for sleep: people with clinical insomnia (see a sleep specialist), sleep apnea (requires CPAP or dental device, not supplements), restless leg syndrome (may need iron evaluation or medication), or circadian rhythm disorders (light therapy and melatonin are first-line). Supplements are appropriate for optimizing already-adequate sleep, not for treating sleep pathology.

Apigenin Dosage Timing and Stacking Protocols

The usual protocol is 50 mg of apigenin 30 to 60 minutes before bed. Stacking it with magnesium and L-theanine is popular, but the one randomized trial of that evening blend found no sleep or stress benefit over two weeks in healthy adults (Mastrofini et al., 2026). If you stack, change one thing at a time and track whether your sleep actually improves.

Timing is based on reasoning rather than data. Taking apigenin 30 to 60 minutes before bed lines up any calming effect with the time you try to sleep, but no study has compared dosing times.

Any CD38-related effect would build over days rather than hours, so consistency matters more than exact timing for that part of the mechanism.

Simple protocol (one supplement): 50 mg apigenin 30–60 minutes before bed with a small fat-containing snack (a few nuts, a spoonful of nut butter). The fat enhances flavonoid absorption. Alternatively, 2 cups of strong chamomile tea beginning 45–60 minutes before bed.

Intermediate protocol (two supplements): Magnesium glycinate 200–400 mg with dinner (addresses mineral status, NMDA receptor modulation, and promotes muscle relaxation) + apigenin 50 mg 30–60 minutes before bed (adds GABA-A modulation and CD38 inhibition). This combination addresses two distinct aspects of the sleep process with non-overlapping mechanisms.

Advanced protocol (three supplements): magnesium with dinner, then L-theanine 200 mg and apigenin 50 mg before bed. This is close to the evening blend tested in 2026, which did not improve sleep in healthy adults over two weeks (Mastrofini et al., 2026). It is worth trying only if simpler steps have failed.

One important caution about stacking: combining multiple GABAergic supplements (apigenin + valerian + GABA + phenibut) can produce excessive sedation and should be avoided. Stick to mechanistically diverse combinations rather than stacking multiple GABA-A modulators.

Apigenin and Anxiety: The Broader Evidence

The chamomile evidence is somewhat stronger for generalized anxiety than for sleep. An 8-week RCT found modest anxiolytic effects (Amsterdam et al., 2009), and in a 26-week continuation study chamomile kept anxiety symptoms lower than placebo but did not significantly reduce relapse (Mao et al., 2016). A 2019 meta-analysis judged chamomile efficacious for sleep quality and generalized anxiety disorder, with little evidence for insomnia (Hieu et al., 2019).

The Amsterdam trial was the first randomized, double-blind, placebo-controlled study of chamomile extract for generalized anxiety disorder. Of 61 enrolled outpatients, 57 were randomized to chamomile or placebo for 8 weeks. Anxiety scores (HAM-A) fell more with chamomile (P = 0.047), and the authors concluded that chamomile may have modest anxiolytic activity (Amsterdam et al., 2009).

Mao and colleagues then gave 179 people with generalized anxiety 12 weeks of open-label chamomile extract (1,500 mg/day). The 93 responders were randomized to continue chamomile or switch to placebo for 26 weeks. Relapse occurred in 15.2% with chamomile versus 25.5% with placebo, a difference that was not statistically significant. Chamomile did keep anxiety symptoms lower and was linked to small reductions in body weight and blood pressure (Mao et al., 2016).

A 2019 systematic review and meta-analysis of 12 RCTs concluded that chamomile appears efficacious and safe for sleep quality and generalized anxiety disorder, while evidence for state anxiety and insomnia was weak (Hieu et al., 2019).

Even chamomile inhalation may help. In 80 young adults with insomnia, 15 nights of chamomile oil inhalation before bed reduced both PSQI sleep quality scores and insomnia severity scores compared with a control oil, with no adverse events (Deepa et al., 2025). The route is different from oral supplementation, but the consistency across delivery methods strengthens the case for chamomile as a sleep aid.

This has practical implications for how you think about apigenin for sleep. If your sleep difficulty is primarily anxiety-driven, you lie in bed with racing thoughts, worry about falling asleep, or experience physical tension at bedtime, the anxiolytic evidence for apigenin is relatively strong and directly applicable. If your sleep difficulty is circadian (you cannot sleep at the right time), pain-related, or due to sleep apnea, apigenin's mechanism is less likely to help because it does not address these causes.

Apigenin Beyond Sleep: Anti-Cancer and Anti-Inflammatory Research

Apigenin shows anti-cancer activity in cell and animal studies, including cell-cycle arrest and programmed death of cancer cells (Shankar et al., 2017). It also acts on inflammatory pathways (Kramer et al., 2024). None of this has been shown in human trials, so it is not a reason to take apigenin.

The anti-cancer literature on apigenin is large and spans many cancer types, almost entirely in cell culture and animal models (Shankar et al., 2017).

The mechanisms underlying these anti-cancer effects include direct activation of p53 (the "guardian of the genome" tumor suppressor protein), inhibition of PI3K/Akt and MAPK signaling pathways that drive cancer cell survival, suppression of cyclooxygenase-2 (COX-2) expression that promotes tumor inflammation and growth, and inhibition of HIF-1α which cancers use to adapt to low-oxygen environments (Shankar et al., 2017).

The key caveat: these effects come from cell culture and animal models. The concentrations used in cell studies are likely far higher than what oral supplements reach in blood, and no human trial has shown that apigenin prevents or treats any cancer (Shankar et al., 2017).

The anti-inflammatory effects are more plausible at supplement doses, but they also come mainly from laboratory work (Salehi et al., 2019) (Kramer et al., 2024).

The CD38 link also explains why apigenin appears in anti-aging stacks: by blocking NAD+ breakdown, it raised NAD+ and lowered protein acetylation in mice, consistent with higher sirtuin activity (Escande et al., 2013). It is often paired with NMN, which supplies an NAD+ precursor, though that combination has not been tested in trials.

Common Mistakes When Supplementing Apigenin

The most common mistakes include expecting pharmaceutical-grade sedation (apigenin is an anxiolytic, not a sedative), taking it with a high-protein meal that may compete for absorption, combining it with other strong GABA modulators without considering additive effects, and evaluating it after only a few days rather than allowing 2–4 weeks for consistent benefit to develop.

Expecting sedation — Apigenin is frequently described as a "natural sleep supplement," which creates expectations of drowsiness similar to melatonin, diphenhydramine, or prescription sleep aids. In reality, apigenin is an anxiolytic that reduces pre-sleep anxiety and promotes calm, it does not directly induce drowsiness. If you take apigenin expecting to feel noticeably sleepy within 30 minutes, you will likely be disappointed. The effect is more subtle: reduced mental chatter, easier transition from wakefulness to sleep-readiness, and potentially deeper sleep quality once you do fall asleep.

Wrong timing or food pairing. Taking apigenin with a large, high-protein meal may reduce its absorption, as protein digestion competes for gut transport resources. The ideal pairing is a small fat-containing snack (not a full meal) 30–60 minutes before bed. Taking it too early in the evening may mean the peak anxiolytic effect has passed by the time you actually try to sleep. Taking it immediately before lying down does not allow enough time for absorption and receptor binding.

Stacking too many GABA modulators. Combining apigenin with valerian root, GABA supplements, phenibut, kava, or alcohol creates additive effects on inhibitory neurotransmission. While apigenin alone is a gentle partial agonist, combining it with other GABA modulators can produce excessive sedation, cognitive impairment, and in extreme cases respiratory depression. If you take prescription benzodiazepines or gabapentinoids (gabapentin, pregabalin), add apigenin only with your physician's awareness.

Evaluating too quickly. Some users try apigenin for 2–3 nights, notice no dramatic sleep change, and conclude it does not work. The chamomile extract trials that showed positive results measured outcomes after 28 days of consistent use. The GABA-A modulation may produce some acute benefit, but the full effects, including the CD38/NAD+ preservation and anti-inflammatory contributions, develop over weeks of regular use. Give apigenin a minimum 2-week consistent trial before evaluating its effects on your sleep quality (Adib-Hajbaghery & Mousavi, 2017).

Choosing low-quality supplements. Not all apigenin supplements are equivalent. Some products use synthetic apigenin, others use chamomile-derived apigenin, and quality varies widely. Look for supplements that specify apigenin content per capsule (not just "chamomile extract 500 mg" without standardization), provide third-party testing certificates, and use vegetarian capsules without unnecessary fillers. Brands that specify "from chamomile extract" tend to more closely match the form used in clinical research.

Does apigenin actually help you sleep?

Possibly, but the evidence is thin. In mice, apigenin acts on GABA-A receptors (Viola et al., 1995), and chamomile extract improves sleep quality scores in people (Kazemi et al., 2024). Isolated apigenin has not been tested alone, and a blend containing 50 mg did not improve sleep in healthy adults (Mastrofini et al., 2026). It is most likely to help if anxiety keeps you awake.

How much apigenin should I take for sleep?

The common dose is 50 mg taken 30 to 60 minutes before bed, popularized by Andrew Huberman rather than by a trial. If you prefer evidence-backed dosing, chamomile extract at 200 mg twice daily improved sleep quality in older adults (Adib-Hajbaghery & Mousavi, 2017).

Is apigenin the same as chamomile?

No. Apigenin is one of many active compounds in chamomile, alongside bisabolol, chamazulene and other flavonoids. The human sleep and anxiety data come from whole chamomile extract (Kazemi et al., 2024) (Hieu et al., 2019), so it is not known whether apigenin alone produces the same effects.

Can you take apigenin every night?

Probably, though long-term data on isolated apigenin are lacking. Chamomile extract was used daily for 26 weeks with low adverse event rates similar to placebo (Mao et al., 2016). If you take warfarin, ask your doctor first, since chamomile may add to bleeding risk (Tan & Lee, 2021).